{
  "id": "fdfd8a7ee5664de8",
  "title": "STAT+: Pharmalittle: We\u2019re reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, and more",
  "description": "In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, and more.",
  "content": "In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, and more.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2025/12/09/fda-rsv-merck-sanofi-astrazeneca-abortion-glp1/?utm_campaign=rss",
  "published_at": "2025-12-09T14:19:29+00:00",
  "fetched_at": "2025-12-10T00:22:54.894572+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, and more",
    "description": "In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, and more.",
    "url": "https://www.statnews.com/pharmalot/2025/12/09/fda-rsv-merck-sanofi-astrazeneca-abortion-glp1/?utm_campaign=rss",
    "published": "2025-12-09T14:19:29+00:00",
    "source": "STAT"
  }
}